Par Drugs and Chemicals Limited — Important, 10-02-2026: Updates

Par Drugs and Chemicals approved financial results for the quarter and nine-month ending December 2025. Q3 revenue surged to ₹29.34 Cr, with profit jumping to ₹4.80 Cr from ₹0.58 Cr YoY. Nine-month revenue hit ₹84.04 Cr, yielding ₹12.25 Cr profit. The company also amended its Related-Party Transactions policy and paid ₹0.11 Cr in employee earned leave.